Three years ago today, our final Phase IIA trial results were released. Since then, we have still not put a jab in an arm for our next trial, despite these outstanding results. I will admit back then I did not think not starting the trial by now was even a remote possibility. Who is to blame?
Ann: Trial Met Primary & Exceeded Secondary Endpoint Expectations, page-223
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.0¢ |
Change
-0.002(2.78%) |
Mkt cap ! $64.91M | |||
| Open | High | Low | Value | Volume |
| 7.2¢ | 7.3¢ | 7.0¢ | $77.28K | 1.090M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20045 | 7.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.1¢ | 75177 | 1 |
View Market Depth
| Last trade - 14.57pm 30/04/2024 (20 minute delay) ? |
|
|||||
|
Last
7.1¢ |
Change
-0.002 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 7.2¢ | 7.3¢ | 7.0¢ | 99240 | ||
| Last updated 15.30pm 30/04/2024 ? | |||||
| PER (ASX) Chart |